SOMA COMPOUND (nda012365)- (325MG;200MG)

Generic Name	ASPIRIN; CARISOPRODOL	Innovator	MEDA PHARMS
Dosage	325MG;200MG
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2002-Aug-13	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Soma Compound is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
325MG;200MG	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of SOMA COMPOUND